Another "CRISPR Calamity"? U.K. Team Reports CRISPR-Induced Gene Rearrangements
New Findings Call the Precision of CRISPR-Cas9 Gene Editing into Question
Enabling the Rise of a CRISPR World
As the World Debates Genome Editing Regulations, the Scientific Community Continues the Push to Democratize CRISPR
Organs-on-Chips Take Flight
Initiative to Use Technology Aboard International Space Station Set to Begin
Top 10 Biopharma IPOs of January—June 2018
Number of Companies Going Public, and the Amount They Raise, Show Growth
Ann Rossi Ph.D.
Ann Rossi, Ph.D., works as an applications lab manager at Corning Life Sciences.
More GEN Content From This Contributor
- Tutorials: 3D Glioma Blood–Brain Barrier Model